SCHEMBL4766646

SCHEMBL4766646

CC(C)CC(NC(=O)c1ccc2ccccc2n1)C(=O)N(C(=O)Nc1ccccc1F)[C@H]1CCCNCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 4/20 0.45
CTSL P07711 2/20 0.45
CTSB P07858 2/20 0.45
CTSS P25774 2/20 0.45
UTS2R Q9UKP6 1/20 0.39
NPC1 O15118 2/20 0.37
CNR2 P34972 2/20 0.36
CNR1 P21554 1/20 0.36
CCR1 P32246 1/20 0.36
NTRK3 Q16288 1/20 0.35
NTRK2 Q16620 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
GRN P28799 1/20 0.35
SORT1 Q99523 1/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
NFKB1 P19838 1/20 0.35
RECQL P46063 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763005 0.83 TAS1R3 (0.48) CTSKCTSBCTSSUTS2RNPC1
SCHEMBL6605727 0.81 NPC1 (0.37) NPC1MEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL4765540 0.81 NPC1 (0.37) CTSKCTSLCTSBCTSSNPC1
SCHEMBL7037396 0.80 NPC1 (0.39) NPC1MEN1MAPTKMT2ARAB9A
SCHEMBL4768735 0.80 CTSK (0.36) CTSKUTS2RNPC1RAB9ASMN1; SMN2
SCHEMBL4761946 0.79 TAS1R3 (0.50) CTSKCTSLCTSBCTSSNPC1
SCHEMBL4765600 0.78 CTSK (0.54) CTSKCTSLCTSBCTSSUTS2R
SCHEMBL4761986 0.74 GRN (0.47) CTSKCTSLCTSBCTSSCNR2
SCHEMBL4765859 0.74 GRN (0.47) CTSKCTSLCTSBCTSSCNR2
SCHEMBL4770129 0.74 LMNA (0.37) NPC1MEN1KMT2ARAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1307204-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2004-06-02 EP claimed
EP-1307204-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-05-07 EP claimed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO claimed
EP-1320370-A4 METHOD OF TREATMENT SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed
EP-1320370-A1 METHOD OF TREATMENT SmithKline Beecham Corporation (US) 2003-06-25 EP disclosed
WO-2002017924-A1 METHOD OF TREATMENT SMITHKLINE BEECHAM CORPORATION (GB) 2002-03-07 WO disclosed